Ocular Therapeutix Inc (OCUL)
5.65
-0.19
(-3.25%)
USD |
NASDAQ |
May 10, 16:00
5.65
0.00 (0.00%)
After-Hours: 20:00
Ocular Therapeutix Cash from Investing (Quarterly): -0.459M for Dec. 31, 2023
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -0.459M |
| September 30, 2023 | -0.259M |
| June 30, 2023 | -1.99M |
| March 31, 2023 | -3.379M |
| December 31, 2022 | -2.15M |
| September 30, 2022 | -0.794M |
| June 30, 2022 | -0.495M |
| March 31, 2022 | -0.276M |
| December 31, 2021 | -0.631M |
| September 30, 2021 | -0.276M |
| June 30, 2021 | -0.129M |
| March 31, 2021 | -0.158M |
| December 31, 2020 | -0.253M |
| September 30, 2020 | -0.214M |
| June 30, 2020 | -0.125M |
| March 31, 2020 | -0.249M |
| December 31, 2019 | -0.601M |
| September 30, 2019 | -0.419M |
| June 30, 2019 | -0.493M |
| March 31, 2019 | -0.725M |
| December 31, 2018 | -0.479M |
| September 30, 2018 | -0.473M |
| Date | Value |
|---|---|
| June 30, 2018 | -0.556M |
| March 31, 2018 | -0.381M |
| December 31, 2017 | -0.564M |
| September 30, 2017 | 0.969M |
| June 30, 2017 | 18.70M |
| March 31, 2017 | 7.846M |
| December 31, 2016 | -10.88M |
| September 30, 2016 | 11.32M |
| June 30, 2016 | 11.76M |
| March 31, 2016 | 24.87M |
| December 31, 2015 | -2.086M |
| September 30, 2015 | -27.59M |
| June 30, 2015 | 8.958M |
| March 31, 2015 | -17.85M |
| December 31, 2014 | -37.77M |
| September 30, 2014 | -0.274M |
| June 30, 2014 | -0.248M |
| March 31, 2014 | -0.297M |
| December 31, 2013 | -0.206M |
| September 30, 2013 | -0.109M |
| June 30, 2013 | -0.051M |
| March 31, 2013 | -0.021M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-3.379M
Minimum
Mar 2023
-0.125M
Maximum
Jun 2020
-0.7026M
Average
-0.419M
Median
Sep 2019
Cash from Investing (Quarterly) Benchmarks
| Amgen Inc | -217.00M |
| Assertio Holdings Inc | 0.00 |
| CytomX Therapeutics Inc | 12.87M |
| EyePoint Pharmaceuticals Inc | -47.15M |
| Cormedix Inc | 0.5978M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -22.45M |
| Cash from Financing (Quarterly) | 108.17M |
| Free Cash Flow | -76.32M |
| Free Cash Flow Per Share (Quarterly) | -0.2539 |
| Free Cash Flow to Equity (Quarterly) | -23.95M |
| Free Cash Flow Yield | -16.33% |